Free Trial
NASDAQ:EKSO

Ekso Bionics (EKSO) Stock Price, News & Analysis

Ekso Bionics logo
$3.49 +0.10 (+2.95%)
Closing price 04:00 PM Eastern
Extended Trading
$3.32 -0.18 (-5.01%)
As of 06:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Ekso Bionics Stock (NASDAQ:EKSO)

Key Stats

Today's Range
$3.31
$3.57
50-Day Range
$2.82
$114.41
52-Week Range
$2.73
$22.95
Volume
47,657 shs
Average Volume
78,376 shs
Market Capitalization
$8.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$562.50
Consensus Rating
Buy

Company Overview

Ekso Bionics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
69th Percentile Overall Score

EKSO MarketRank™: 

Ekso Bionics scored higher than 69% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Ekso Bionics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Ekso Bionics has only been the subject of 1 research reports in the past 90 days.

  • Read more about Ekso Bionics' stock forecast and price target.
  • Earnings Growth

    Earnings for Ekso Bionics are expected to grow in the coming year, from ($0.48) to ($0.15) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Ekso Bionics is -0.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Ekso Bionics is -0.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Ekso Bionics has a P/B Ratio of 0.40. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Ekso Bionics' valuation and earnings.
  • Percentage of Shares Shorted

    1.30% of the float of Ekso Bionics has been sold short.
  • Short Interest Ratio / Days to Cover

    Ekso Bionics has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Ekso Bionics has recently decreased by 64.19%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Ekso Bionics does not currently pay a dividend.

  • Dividend Growth

    Ekso Bionics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.30% of the float of Ekso Bionics has been sold short.
  • Short Interest Ratio / Days to Cover

    Ekso Bionics has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Ekso Bionics has recently decreased by 64.19%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Ekso Bionics has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.90 average news sentiment score of Medical companies.
  • Search Interest

    Only 1 people have searched for EKSO on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Ekso Bionics to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Ekso Bionics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.10% of the stock of Ekso Bionics is held by insiders.

  • Percentage Held by Institutions

    Only 6.42% of the stock of Ekso Bionics is held by institutions.

  • Read more about Ekso Bionics' insider trading history.
Receive EKSO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ekso Bionics and its competitors with MarketBeat's FREE daily newsletter.

EKSO Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
See More Headlines

EKSO Stock Analysis - Frequently Asked Questions

Ekso Bionics' stock was trading at $137.25 on January 1st, 2025. Since then, EKSO stock has decreased by 97.5% and is now trading at $3.49.
View the best growth stocks for 2025 here
.

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) announced its earnings results on Monday, May, 5th. The company reported ($27.00) earnings per share for the quarter, missing the consensus estimate of ($24.75) by $2.25. The business had revenue of $3.38 million for the quarter, compared to analyst estimates of $4.62 million. Ekso Bionics had a negative trailing twelve-month return on equity of 82.50% and a negative net margin of 61.51%.
Read the conference call transcript
.

Ekso Bionics's stock reverse split before market open on Tuesday, May 27th 2025.The 1-15 reverse split was announced on Monday, May 19th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 26th 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of EKSO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ekso Bionics investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), TransEnterix (TRXDW), Meta Platforms (META), Tesla (TSLA), Editas Medicine (EDIT) and Micron Technology (MU).

Company Calendar

Last Earnings
5/05/2025
Today
7/02/2025
Next Earnings (Estimated)
8/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Machinery
Current Symbol
NASDAQ:EKSO
Previous Symbol
OTCMKTS:EKSOD
Employees
60
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$562.50
High Stock Price Target
$900.00
Low Stock Price Target
$225.00
Potential Upside/Downside
+16,444.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$11.33 million
Pretax Margin
-61.51%

Debt

Sales & Book Value

Annual Sales
$17.92 million
Price / Cash Flow
N/A
Book Value
$8.66 per share
Price / Book
0.39

Miscellaneous

Free Float
2,210,000
Market Cap
$7.99 million
Optionable
Optionable
Beta
0.81

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:EKSO) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners